ARNS partners and exhibitors have had no input into the agenda of the conference, apart from sponsored symposia.
Thank you to all our Partners:
Astrazeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas- Oncology, Cardiovascular, Renal & Metabolism and Respiratory. For more information, please visit www.astrazeneca.co.uk.
Boehringer Ingelheim has 100 years of heritage in respiratory disease.
Since 1921 we have emerged as a leader in this disease area, having developed and launched treatments for a range of respiratory conditions including lung cancer, asthma, chronic obstructive pulmonary disease (COPD), treatment of adults with idiopathic pulmonary fibrosis (IPF) and other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype.
Our continued focus is on improving the life of patients suffering from debilitating respiratory diseases.
PC-GB-105963 Date of preparation; November 2021
Boehringer Ingelheim (BI) has provided financial support to ARNS as a partnership for 2023. The funding enabled ARNS to provide ongoing education and development for respiratory nurses. BI has had no input into ARNS activities other than an exhibition stand and a symposium slot at the annual conference.
Based in Parma, Italy, Chiesi Farmaceutici is an international research-focused biopharmaceuticals group with over 85 years’ experience in the pharmaceutical sector operating in 30 countries, employing around 6,000 people. Chiesi develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. As a certified B Corp since 2019, Chiesi is part of a global community of businesses that meet high standards of social and environmental impact. Chiesi Limited is headquartered in Manchester employing over 400 people.
Insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. We are powered by purpose, a purpose to serve patients and their families with unwavering dedication. A purpose to find solutions where there were none before. A purpose to do what’s right, even when it isn’t easy. A biotech company that empowers great people to deliver, with a profound sense of urgency and compassion, life-altering therapies to small patient populations experiencing big health problems.
A global leader in interventional pulmonology, planning tools, and treatments for obstructive lung disease.
Based in Redwood City, California, and Neuchâtel, Switzerland, Pulmonx is the maker of the Zephyr Endobronchial Valve. The Zephyr® Valve was granted breakthrough status and approved by the FDA in June 2018, because according to the FDA it “represents a breakthrough technology as the device offers bronchoscopic lung volume reduction without surgery and its associated risks. This device offers a significant, clinically meaningful advantage over the current standard of care and therefore, its availability is also in the best interest of patients.”
The company’s commercially available portfolio includes the Zephyr Endobronchial Valve. More than 100 scientific articles have been published on the clinical benefits of Zephyr Valves, including multiple meta-analyses, review articles, cost-effectiveness analyses and risk-benefit analyses.
Thank you to all our Exhibitors:
Headquartered in Galway, Ireland, Aerogen is the world leader in acute care aerosol drug delivery. With over 20 years of experience, 300 international patents and 200+ clinical papers, Aerogen technology has been used to treat 16 million patients in 75 countries worldwide. Based on a pioneering vibrating mesh technology, the Aerogen Solo has become the gold standard for respiratory patient care across the hospital from the emergency department to intensive care.
The company continues to leverage their expertise, research, technologies and partnerships to make the greatest possible difference to patient outcomes.
We are a dynamic pharmaceutical company who are committed to building and nurturing meaningful partnerships with our customers in the UK. We are dedicated to delivering a growing portfolio of high quality products to help improve patient outcomes, at responsible prices. This is in accordance with our values of Integrity, Partnership and Reliability.
Tel: +44 (0)1908 038083
Email: info@alturix.com
Medical Information
Tel: +44 (0) 845 5191609
Email: medinfo@alturix.com
Linked In: https://www.linkedin.com/company/alturix
Asthma Patients Can Now Breathe Easy.
CAIRE® Diagnostics enables asthma patients to live with confidence through better monitoring and control. CAIRE® Diagnostics manufactures Fenom Pro®, a simple, easy to use, point of care device that measures Fractional exhaled Nitric Oxide (FeNO). FeNO is an accepted biomarker for inflammation associated with allergic asthma. CAIRE® Diagnostics is working to create broader access to FeNO testing for all asthmatics regardless of where they seek care around the world. Find out more about CAIRE® Diagnostics and Fenom Pro® at www.fenomasthma.com.
Manufacturing respiratory devices for over 100 years. A wealth of experience supporting health providers to assess, diagnose and manage respiratory conditions with our range of high-quality, hand-calibrated devices - all made in the UK for accuracy and reassured efficacy on treating patients with the best course of care.
A complete range of natural products for the treatment and prevention of allergic symptoms, caused by airborne allergens such as pollen, house dust, or animal dander.
Irwin Mitchell’s reputation for helping clients & their families with a wide range of personal legal issues is second to none. Our highly specialised team combines powerful legal knowledge & experience with care & consideration to ensure that clients receive the best possible support & guidance throughout their claim and beyond.
- lee.simpson@irwinmitchell.com
- www.irwinmitchell.com
- 07917 287 705
Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company, Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. Siemens Healthineers, which has approximately 69,500 employees worldwide. Further information is available at www.siemens-healthineers.co.uk
Trudell Medical International works with patients, their caregivers and healthcare professionals to help patients all over the world breathe better and live fuller lives. We manufacture and globally market some of the leading brands in respiratory care including the AeroChamber* brand of spacers, Aerobika* OPEP devices, and AEROECLIPSE* BAN* nebulisers.
Our mission is to improve patients’ lives by providing market leading products and services. Our intention is to have an impact in the effective management of respiratory diseases. We provide a wide variety of precise, intuitive devices for respiratory care including spirometers, lung & asthma monitors, COPD screeners, ECG, FeNO, and medical workstations as well as software and consumables.
We are excited to showcase our next generation PC-based, desktop and handheld spirometers. Compliant with the 2019 ATS/ERS spirometry update, these devices ensure your service meets the latest international guidelines on accuracy and reporting. Their brand-new intuitive interfaces automatically grade tests and provide quality control feedback for easy and rapid testing.
For further peace of mind these come with FREE 5 YEAR WARRANTY and FREE ONLINE DEVICE TRAINING and FREE CONNECT electronic medical record interface software.
Protect your patients, staff, and equipment with an Eco BVF™, suitable for most leading brands of spirometers. Independently validated 99.999% bacterial and viral cross-contamination efficiency, these filters are made using less plastic, are lighter to transport, and are made from 100% recyclable materials.
Our friendly and knowledgeable experts will be available throughout the conference to chat about your needs.
Visit www.vitalograph.co.uk or call 01280 827110.